Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESPOND paediatric septic shock trial of vitamin C and hydrocortisone
ACTRN12621000247875Phase 2Active, not recruiting
- Sponsor
- The University of Queensland
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, randomised, open-label trial of ascorbic acid and hydrocortisone in sepsis and septic shock (3 arms), sponsored by The University of Queensland. Primary endpoint: Time alive and free of vasopressors. Started Dec 2021; status: active, not recruiting.
02
Drugs
ascorbic acidhydrocortisone
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on ACTRN12621000247875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000247875.